AtriCure (ATRC) Liabilities and Shareholders Equity (2010 - 2026)

AtriCure (ATRC) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $676.6 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 11.13% year-over-year to $676.6 million; the TTM figure through Jun 2026 stood at $2.6 billion (up 7.64% YoY), while the FY2025 annual figure was $654.2 million, up 7.36% from the prior year.
• Liabilities and Shareholders Equity rose to $676.6 million in Q2 2026 per ATRC's latest filing, from $644.0 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $676.6 million in Q2 2026 and bottomed at $581.9 million in Q3 2022.
• Historically, Liabilities and Shareholders Equity has averaged $608.6 million across 5 years, with a median of $598.8 million in 2023.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity decreased 16.42% — and 2026, when it rose 11.13%.
• AtriCure's Liabilities and Shareholders Equity stood at $585.4 million in 2022, then climbed by 4.87% to $613.9 million in 2023, then dropped by 0.75% to $609.3 million in 2024, then climbed by 7.36% to $654.2 million in 2025, then grew by 3.43% to $676.6 million in 2026.
• Business Quant data shows ATRC's Liabilities and Shareholders Equity at $676.6 million in Q2 2026, $644.0 million in Q1 2026, and $654.2 million in Q4 2025.